Long-term outcome of irradiation with or without chemotherapy for esophageal squamous cell carcinoma: a final report on a prospective trial

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Liu, Mina ^a   Shi, Xuehui ^a   Guo, Xiaomao ^a   Yao, Weiqiang ^a   Liu, Yong ^a   Zhao, Kuaile ^a   Jiang, Guo Liang ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Chemoradiation; Esophageal squamous cell carcinoma; Long term follow up

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; CONTROLLED STUDY; COUGHING; DISTANT METASTASIS; DRUG EFFICACY; DRUG SAFETY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; HEART FAILURE; HEMOPTYSIS; HUMAN; LATE COURSE ACCELERATED HYPERFRACTIONATED IRRADIATION; LIVER METASTASIS; LONG TERM CARE; LUNG FIBROSIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE ORGAN FAILURE; OVERALL SURVIVAL; PERICARDITIS; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; STOMACH METASTASIS; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RADIOSURGERY; TIME; TREATMENT OUTCOME; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; FOLLOW-UP STUDIES; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE;

EID: 84865155958     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-142     Document Type: Article

References (14)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
2. Shi XH, Yao W, Liu T. Late course accelerated fractionation in radiotherapy of esophageal carcinoma. Radiother Oncol 1999, 51(1):21-26. 10.1016/S0167-8140(99)00017-1, 10450568.
3. Zhao KL, Shi XH, Jiang GL, et al. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study. Int J Radiat Oncol Biol Phys 2005, 62(4):1014-1020. 10.1016/j.ijrobp.2004.12.022, 15990003.
4. Zhao KL, Shi XH, Jiang GL, et al. Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma. Int J Radiat Oncol Biol Phys 2004, 60(1):123-129. 10.1016/j.ijrobp.2004.02.058, 15337547.
5. Zhao KL, Wang Y, Shi XH. Late course accelerated hyperfractionated radiotherapy for clinical T1-2 esophageal carcinoma. World J Gastroenterol 2003, 9(6):1374-1376.
6. Liu CX, Li XY, Gao XS. Meta-analysis of late course accelerated hyperfractionated radiotherapy combined with FP chemotherapy for esophageal carcinoma. Chin J Cancer 2010, 29(10):889-899. 10.5732/cjc.010.10147, 20868559.
7. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (rtog 85-01). JAMA 1999, 281(17):1623-1627. 10.1001/jama.281.17.1623, 10235156.
8. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combinedmodality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002, 20:1167-1174. 10.1200/JCO.20.5.1167, 11870157.
9. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy in patients with cancer of the esophagus. N Engl J Med 1992, 326:1593-1598. 10.1056/NEJM199206113262403, 1584260.
10. Al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an Intergroup study. J Clin Oncol 1997, 15:277-284.
11. Morota MK, Gomi KR, Kozuka TY, et al. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 2009, 75(1):122-128. 10.1016/j.ijrobp.2008.10.075, 19327900.
12. Muzaffar M, Khuder S, Mohamed I. Conditional survival of patients with esophageal cancer: a SEER database analysis. J Clin Oncol 2011, 29:e14597.
13. Barnett G, De Meerleer G, Gulliford S, et al. The impact of clinical factors on the development of late radiation toxicity: results from the medical research council RT01 trial (ISRCTN47772397). Clin Oncol 2011, 23:613-624.
14. Birgisson H, Pahlman L, Gunnarsson U, et al. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 2008, 95:206-213.